HER2-postive Breast Cancer Expert Series Resources
BC Expert Series Webinar 1: Treatment closer to home - A new era for patients with breast cancer
Watch Professors Wardley and Jackisch discuss the status and importance of flexible care in shaping the future of breast cancer treatment.
BC Expert Series Webinar 2: Neoadjuvant therapy - A multidisciplinary approach to patient care
Watch Professor Harbeck and Mr Cain discuss key considerations for the management of HER2-positive eBC from a surgeon and oncologist perspective.
BC Expert Series Webinar 3 : Diagnostic work-up in HER2-positive eBC: A focus on pathology
Watch Professor Viale discuss the HER2 scoring system, heterogeneity of HER2-positive BC and the pathologist's role in post-NACT setting and response assesment.
BC Expert Series Webinar 4 : Adjuvant treatment in HER2-positive eBC
Watch Professor Swain discuss the optimal treatment regimen for patients with low-risk and high-risk HER2-positive eBC.
BC Expert Series Webinar 5 : Residual disease after neoadjuvant therapy: A new decision point in HER2-positive eBC
Watch Professors Loibl and Geyer discuss the KATHERINE study and its exploratory analyses of clinical interest.
BC Expert Series Webinar 6 : Decreasing the burden: Balancing efficacy, toxicity and patient QoL
Watch Professor Piccart evaluate strategies for personalising treatment options, reducing toxicity and optimising quality of life for patients with HER2-positive eBC.
BC Expert Series Webinar 7 : The evolving treatment landscape in HER2-positive mBC
Watch Doctor Prat discuss the current treatment algorithm and standard of care for HER2-positive mBC, together with recently approved novel agents in the disease.
BC Expert Series Webinar 8 : Patient-expert dialogue: Shared decision making in eBC care
Watch Professor de Azambuja, Mr Harvey and Mrs de Rooij-van Haaren discuss the importance of patient–physician dialogue and shared decision-making in selecting the optimal treatment for patients.